FDA Reminder Ad Scrutiny: Viagra Valentine, Flonase Flora Cited
Executive Summary
FDA's ad division is looking for drug "reminder" ads that go too far in terms of implied product claims, Division of Drug Marketing, Advertising & Communications Branch Chief Nancy Ostrove, PhD, indicated at a Drug Information Association meeting in New York City Feb. 28.
You may also be interested in...
Disease Awareness Ad Guidance Stresses Need For “Distinct” Messages
The impact of FDA's draft guidance on disease awareness ads will depend upon how willing manufacturers are to allot portions of their advertising budgets to non-branded ads
Disease Awareness Ad Guidance Stresses Need For “Distinct” Messages
The impact of FDA's draft guidance on disease awareness ads will depend upon how willing manufacturers are to allot portions of their advertising budgets to non-branded ads
Patient Testimonials Must Be “Typical” For Rx, FDA’s Ostrove Says
Patient testimonials in prescription drug ads should illustrate "typical" experiences among patients on the medication, FDA Division of Drug Marketing, Advertising & Communications Deputy Director Nancy Ostrove, PhD, told a Food & Drug Law Institute conference Oct. 17 in Washington, D.C